Joint Continental Situation Report on the Mpox Epidemic in Africa (23 September- 03 November 2024)
1. Key Highlights in the last 28 days Notable trends in epidemiology, surveillance and containment • The epidemic is not yet contained as additional Member States continue to report outbreaks, driven by clade Ib. • Burundi weekly suspected cases are plateauing, with some fluctuations but the level of transmission remains relatively high. • Liberia had […]
Mpox Joint Africa CDC – WHO SITREP
Executive Summary Summary of major developments during the reporting period (e.g., significant outbreaks, policy changes, vaccination campaigns, etc.). • Africa CDC and WHO established a Technical Review Committee (TRC) as an access and allocation mechanism for mpox vaccines, treatments, and diagnostics. • Nigeria was the first country to receive 10,000 doses of the JYNNEOS mpox […]
A Coordinated Research Roadmap on mpox Virus
ABOUT THIS DOCUMENT A scientific conference was held on August 29-30, 2024. It focused on aligning mpox research with outbreak response goals. This meeting was part of a comprehensive effort to align research initiatives with the practical needs of mpox outbreak control, emphasizing collaboration, regulatory and ethical considerations, and the leadership of affected countries. Over […]
Mpox Continental Preparedness and Response Plan for Africa
Executive Summary On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union (AU) through the Africa CDC and the World […]